Tinea Pedis Treatment Market 2027 By Disease Type, Drug Class, Route of Administration, Distribution Channel | The Insight Partners

Tinea Pedis Treatment Market to 2027 - Global Analysis and Forecasts by Disease Type (Interdigital Tinea Pedis, Plantar Tinea Pedis, Vesicular Tinea Pedis); Drug Class (Antifungals, Steroids and Anti-Infective Combinations); Route of Administration (Topical, Oral); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Report Code: TIPRE00005930 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Tinea Pedis refers to foot infections caused by Trichophyton mentagrophytes and Epidermophyton floccosum. This can also spread to the toenails and the h and s. These fungi increase in warm and humid conditions and can transmit from an infected person to another person.

MARKET DYNAMICS

The Tinea Pedis Treatment market is anticipated to grow in the forecast, owing to the factors such as growing incidence of infectious diseases caused by bacteria, virus and fungus, increasing R&D activities for the treatment of tinea Pedis, rising geriatric population, increased number of immunocompromised patients. Nevertheless, strict approval process is expected to hinder the market growth during the forecast period.

MARKET SCOPE

The "Global Tinea Pedis Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Tinea Pedis Treatment market with detailed market segmentation by disease type, drug class, route of administration, distribution channel and geography. The global Tinea Pedis Treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Tinea Pedis Treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Tinea Pedis Treatment market is segmented on the basis of disease type, drug class, route of administration and distribution channel. Based on disease type the market is segmented into Interdigital Tinea Pedis, Plantar Tinea Pedis, Vesicular Tinea Pedis. Based on drug class the market is segmented into Antifungals, Steroids and Anti-Infective Combinations. Based on route of administration the market is segmented into Topical, Oral. Based on distribution channel the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Tinea Pedis Treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Tinea Pedis Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Tinea Pedis Treatment market from both dem and and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Tinea Pedis Treatment market in these regions.


MARKET PLAYERS

The reports cover key developments in the Tinea Pedis Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Tinea Pedis Treatment market are anticipated to lucrative growth opportunities in the future with the rising dem and for Tinea Pedis Treatment market in the global market. Below mentioned is the list of few companies engaged in the Tinea Pedis Treatment market.

The report also includes the profiles of Tinea Pedis Treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Mylan N.V
- Bausch Health
- GlaxoSmithKline plc
- Novartis AG
- Glenmark Pharmaceuticals Inc., USA
- Aurobindo Pharma Limited
- Aqua Pharmaceuticals LLC
- Bayer AG
- Breckenridge Pharmaceutical, Inc.
- Perrigo Company

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Tinea Pedis Treatment Market - By Disease Type
1.3.2 Tinea Pedis Treatment Market - By Drug Class
1.3.3 Tinea Pedis Treatment Market - By Route of Administration
1.3.4 Tinea Pedis Treatment Market - By Distribution Channel
1.3.5 Tinea Pedis Treatment Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TINEA PEDIS TREATMENT MARKET L and SCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.3. EXPERT OPINIONS
5. TINEA PEDIS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS and RESTRAINTS
6. TINEA PEDIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. TINEA PEDIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. TINEA PEDIS TREATMENT - GLOBAL MARKET and FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. TINEA PEDIS TREATMENT MARKET - REVENUE and FORECASTS TO 2027 - DISEASE TYPE
7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS and ANALYSIS
7.3. INTERDIGITAL TINEA PEDIS
7.3.1. Overview
7.3.2. Interdigital Tinea Pedis Market Forecast and Analysis
7.4. PLANTAR TINEA PEDIS
7.4.1. Overview
7.4.2. Plantar Tinea Pedis Market Forecast and Analysis
7.5. VESICULAR TINEA PEDIS
7.5.1. Overview
7.5.2. Vesicular Tinea Pedis Market Forecast and Analysis
8. TINEA PEDIS TREATMENT MARKET - REVENUE and FORECASTS TO 2027 - DRUG CLASS
8.1. OVERVIEW
8.2. DRUG CLASS MARKET FORECASTS and ANALYSIS
8.3. ANTIFUNGALS
8.3.1. Overview
8.3.2. Antifungals Market Forecast and Analysis
8.4. STEROIDS and ANTI-INFECTIVE COMBINATIONS
8.4.1. Overview
8.4.2. Steroids and Anti-Infective Combinations Market Forecast and Analysis
9. TINEA PEDIS TREATMENT MARKET - REVENUE and FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS and ANALYSIS
9.3. TOPICAL
9.3.1. Overview
9.3.2. Topical Market Forecast and Analysis
9.4. ORAL
9.4.1. Overview
9.4.2. Oral Market Forecast and Analysis
10. TINEA PEDIS TREATMENT MARKET - REVENUE and FORECASTS TO 2027 - DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS and ANALYSIS
10.3. HOSPITAL PHARMACIES
10.3.1. Overview
10.3.2. Hospital Pharmacies Market Forecast and Analysis
10.4. RETAIL PHARMACIES
10.4.1. Overview
10.4.2. Retail Pharmacies Market Forecast and Analysis
10.5. ONLINE PHARMACIES.
10.5.1. Overview
10.5.2. Online Pharmacies. Market Forecast and Analysis
11. TINEA PEDIS TREATMENT MARKET REVENUE and FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Tinea Pedis Treatment Market Overview
11.1.2 North America Tinea Pedis Treatment Market Forecasts and Analysis
11.1.3 North America Tinea Pedis Treatment Market Forecasts and Analysis - By Disease Type
11.1.4 North America Tinea Pedis Treatment Market Forecasts and Analysis - By Drug Class
11.1.5 North America Tinea Pedis Treatment Market Forecasts and Analysis - By Route of Administration
11.1.6 North America Tinea Pedis Treatment Market Forecasts and Analysis - By Distribution Channel
11.1.7 North America Tinea Pedis Treatment Market Forecasts and Analysis - By Countries
11.1.7.1 United States Tinea Pedis Treatment Market
11.1.7.1.1 United States Tinea Pedis Treatment Market by Disease Type
11.1.7.1.2 United States Tinea Pedis Treatment Market by Drug Class
11.1.7.1.3 United States Tinea Pedis Treatment Market by Route of Administration
11.1.7.1.4 United States Tinea Pedis Treatment Market by Distribution Channel
11.1.7.2 Canada Tinea Pedis Treatment Market
11.1.7.2.1 Canada Tinea Pedis Treatment Market by Disease Type
11.1.7.2.2 Canada Tinea Pedis Treatment Market by Drug Class
11.1.7.2.3 Canada Tinea Pedis Treatment Market by Route of Administration
11.1.7.2.4 Canada Tinea Pedis Treatment Market by Distribution Channel
11.1.7.3 Mexico Tinea Pedis Treatment Market
11.1.7.3.1 Mexico Tinea Pedis Treatment Market by Disease Type
11.1.7.3.2 Mexico Tinea Pedis Treatment Market by Drug Class
11.1.7.3.3 Mexico Tinea Pedis Treatment Market by Route of Administration
11.1.7.3.4 Mexico Tinea Pedis Treatment Market by Distribution Channel
11.2. EUROPE
11.2.1 Europe Tinea Pedis Treatment Market Overview
11.2.2 Europe Tinea Pedis Treatment Market Forecasts and Analysis
11.2.3 Europe Tinea Pedis Treatment Market Forecasts and Analysis - By Disease Type
11.2.4 Europe Tinea Pedis Treatment Market Forecasts and Analysis - By Drug Class
11.2.5 Europe Tinea Pedis Treatment Market Forecasts and Analysis - By Route of Administration
11.2.6 Europe Tinea Pedis Treatment Market Forecasts and Analysis - By Distribution Channel
11.2.7 Europe Tinea Pedis Treatment Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Tinea Pedis Treatment Market
11.2.7.1.1 Germany Tinea Pedis Treatment Market by Disease Type
11.2.7.1.2 Germany Tinea Pedis Treatment Market by Drug Class
11.2.7.1.3 Germany Tinea Pedis Treatment Market by Route of Administration
11.2.7.1.4 Germany Tinea Pedis Treatment Market by Distribution Channel
11.2.7.2 France Tinea Pedis Treatment Market
11.2.7.2.1 France Tinea Pedis Treatment Market by Disease Type
11.2.7.2.2 France Tinea Pedis Treatment Market by Drug Class
11.2.7.2.3 France Tinea Pedis Treatment Market by Route of Administration
11.2.7.2.4 France Tinea Pedis Treatment Market by Distribution Channel
11.2.7.3 Italy Tinea Pedis Treatment Market
11.2.7.3.1 Italy Tinea Pedis Treatment Market by Disease Type
11.2.7.3.2 Italy Tinea Pedis Treatment Market by Drug Class
11.2.7.3.3 Italy Tinea Pedis Treatment Market by Route of Administration
11.2.7.3.4 Italy Tinea Pedis Treatment Market by Distribution Channel
11.2.7.4 Spain Tinea Pedis Treatment Market
11.2.7.4.1 Spain Tinea Pedis Treatment Market by Disease Type
11.2.7.4.2 Spain Tinea Pedis Treatment Market by Drug Class
11.2.7.4.3 Spain Tinea Pedis Treatment Market by Route of Administration
11.2.7.4.4 Spain Tinea Pedis Treatment Market by Distribution Channel
11.2.7.5 United Kingdom Tinea Pedis Treatment Market
11.2.7.5.1 United Kingdom Tinea Pedis Treatment Market by Disease Type
11.2.7.5.2 United Kingdom Tinea Pedis Treatment Market by Drug Class
11.2.7.5.3 United Kingdom Tinea Pedis Treatment Market by Route of Administration
11.2.7.5.4 United Kingdom Tinea Pedis Treatment Market by Distribution Channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Tinea Pedis Treatment Market Overview
11.3.2 Asia-Pacific Tinea Pedis Treatment Market Forecasts and Analysis
11.3.3 Asia-Pacific Tinea Pedis Treatment Market Forecasts and Analysis - By Disease Type
11.3.4 Asia-Pacific Tinea Pedis Treatment Market Forecasts and Analysis - By Drug Class
11.3.5 Asia-Pacific Tinea Pedis Treatment Market Forecasts and Analysis - By Route of Administration
11.3.6 Asia-Pacific Tinea Pedis Treatment Market Forecasts and Analysis - By Distribution Channel
11.3.7 Asia-Pacific Tinea Pedis Treatment Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Tinea Pedis Treatment Market
11.3.7.1.1 Australia Tinea Pedis Treatment Market by Disease Type
11.3.7.1.2 Australia Tinea Pedis Treatment Market by Drug Class
11.3.7.1.3 Australia Tinea Pedis Treatment Market by Route of Administration
11.3.7.1.4 Australia Tinea Pedis Treatment Market by Distribution Channel
11.3.7.2 China Tinea Pedis Treatment Market
11.3.7.2.1 China Tinea Pedis Treatment Market by Disease Type
11.3.7.2.2 China Tinea Pedis Treatment Market by Drug Class
11.3.7.2.3 China Tinea Pedis Treatment Market by Route of Administration
11.3.7.2.4 China Tinea Pedis Treatment Market by Distribution Channel
11.3.7.3 India Tinea Pedis Treatment Market
11.3.7.3.1 India Tinea Pedis Treatment Market by Disease Type
11.3.7.3.2 India Tinea Pedis Treatment Market by Drug Class
11.3.7.3.3 India Tinea Pedis Treatment Market by Route of Administration
11.3.7.3.4 India Tinea Pedis Treatment Market by Distribution Channel
11.3.7.4 Japan Tinea Pedis Treatment Market
11.3.7.4.1 Japan Tinea Pedis Treatment Market by Disease Type
11.3.7.4.2 Japan Tinea Pedis Treatment Market by Drug Class
11.3.7.4.3 Japan Tinea Pedis Treatment Market by Route of Administration
11.3.7.4.4 Japan Tinea Pedis Treatment Market by Distribution Channel
11.3.7.5 South Korea Tinea Pedis Treatment Market
11.3.7.5.1 South Korea Tinea Pedis Treatment Market by Disease Type
11.3.7.5.2 South Korea Tinea Pedis Treatment Market by Drug Class
11.3.7.5.3 South Korea Tinea Pedis Treatment Market by Route of Administration
11.3.7.5.4 South Korea Tinea Pedis Treatment Market by Distribution Channel
11.4. MIDDLE EAST and AFRICA
11.4.1 Middle East and Africa Tinea Pedis Treatment Market Overview
11.4.2 Middle East and Africa Tinea Pedis Treatment Market Forecasts and Analysis
11.4.3 Middle East and Africa Tinea Pedis Treatment Market Forecasts and Analysis - By Disease Type
11.4.4 Middle East and Africa Tinea Pedis Treatment Market Forecasts and Analysis - By Drug Class
11.4.5 Middle East and Africa Tinea Pedis Treatment Market Forecasts and Analysis - By Route of Administration
11.4.6 Middle East and Africa Tinea Pedis Treatment Market Forecasts and Analysis - By Distribution Channel
11.4.7 Middle East and Africa Tinea Pedis Treatment Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Tinea Pedis Treatment Market
11.4.7.1.1 South Africa Tinea Pedis Treatment Market by Disease Type
11.4.7.1.2 South Africa Tinea Pedis Treatment Market by Drug Class
11.4.7.1.3 South Africa Tinea Pedis Treatment Market by Route of Administration
11.4.7.1.4 South Africa Tinea Pedis Treatment Market by Distribution Channel
11.4.7.2 Saudi Arabia Tinea Pedis Treatment Market
11.4.7.2.1 Saudi Arabia Tinea Pedis Treatment Market by Disease Type
11.4.7.2.2 Saudi Arabia Tinea Pedis Treatment Market by Drug Class
11.4.7.2.3 Saudi Arabia Tinea Pedis Treatment Market by Route of Administration
11.4.7.2.4 Saudi Arabia Tinea Pedis Treatment Market by Distribution Channel
12. INDUSTRY L and SCAPE
12.1. MERGERS and ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS and JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS and OTHER STRATEGIC DEVELOPMENTS
13. TINEA PEDIS TREATMENT MARKET, KEY COMPANY PROFILES
13.1. MYLAN N.V
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BAUSCH HEALTH
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. GLAXOSMITHKLINE PLC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. NOVARTIS AG
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GLENMARK PHARMACEUTICALS INC., USA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. AUROBINDO PHARMA LIMITED
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. AQUA PHARMACEUTICALS LLC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BAYER AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BRECKENRIDGE PHARMACEUTICAL, INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. PERRIGO COMPANY
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

- Mylan N. V
- Bausch Health
- GlaxoSmithKline plc
- Novartis AG
- Glenmark Pharmaceuticals Inc. , USA
- Aurobindo Pharma Limited
- Aqua Pharmaceuticals LLC
- Bayer AG
- Breckenridge Pharmaceutical, Inc.
- Perrigo Company